HCV NS5 Genotype-2b

Hepatitis C Virus NS5 Genotype-2b Recombinant
Cat. No.
BT16538
Source
Escherichia Coli.
Synonyms
Appearance
Purity
HCV NS5 Genotype-2b protein is >95% pure as determined by 10% PAGE (coomassie staining).
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.coli derived recombinant protein contains the HCV NS5 Genotype 2b immunodominant regions, amino acids 2212-2313. The protein is fused to a GST tag at N-Terminus.

Product Specs

Introduction
Hepatitis C virus (HCV) is a small (50nm), enveloped virus with a single-stranded, positive-sense RNA genome. It belongs to the family Flaviviridae. HCV replicates rapidly, producing about a trillion particles daily in an infected person. The virus's RNA polymerase lacks proofreading ability, resulting in a high mutation rate. This characteristic allows HCV to evade the host's immune response effectively. HCV is categorized into six genotypes (1-6), each with multiple subtypes. The prevalence and distribution of these genotypes vary worldwide. Genotype determination is crucial for clinical management as it influences the response to interferon-based therapy and the treatment duration. Genotypes 1 and 4 are less responsive to interferon-based treatment compared to genotypes 2, 3, 5, and 6.
Description
This recombinant protein is derived from E. coli and encompasses the immunodominant regions of the HCV NS5 protein from genotype 2b, specifically amino acids 2212-2313. A GST tag is fused to the protein's N-terminus.
Purity
The purity of the HCV NS5 Genotype-2b protein exceeds 95%, as determined by 10% SDS-PAGE followed by Coomassie blue staining.
Formulation
The protein is supplied in a buffer containing 1.5M urea, 25 mM Tris-HCl (pH 8.0), 0.2% Triton-X, and 50% glycerol.
Stability
For optimal storage, HCV NS5 Genotype-2b should be stored at -18°C or below. While the protein remains stable at 4°C for up to one week, it is recommended to avoid repeated freeze-thaw cycles.
Applications
The HCV NS5 Genotype-2b antigen is suitable for use in ELISA and Western blot assays. It is a highly effective antigen for detecting HCV, exhibiting minimal cross-reactivity or specificity issues.
Source
Escherichia Coli.
Purification Method
HCV NS5 Genotype-2b protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of HCV-infected individuals.

Product Science Overview

Introduction

Hepatitis C Virus (HCV) is a significant global health concern, affecting millions of people worldwide. It is a bloodborne virus that primarily infects the liver, leading to chronic liver diseases such as cirrhosis, liver fibrosis, and hepatocellular carcinoma if left untreated . HCV is classified into seven major genotypes, each with multiple subtypes . Among these, genotype 2b is of particular interest due to its unique characteristics and clinical implications.

Structure and Function of NS5

The nonstructural protein 5 (NS5) of HCV is a multifunctional protein that plays a crucial role in the viral replication cycle. NS5 is divided into two regions: NS5A and NS5B. NS5A is involved in viral RNA replication and modulation of the host cell environment, while NS5B functions as an RNA-dependent RNA polymerase, essential for viral RNA synthesis . The NS5 region is a target for antiviral therapies, making it a critical focus of HCV research.

Genotype 2b and Recombinant Forms

Genotype 2b is one of the subtypes of HCV genotype 2, which is less prevalent compared to genotypes 1 and 3 but still significant in certain regions . Recombinant forms of HCV, such as the NS5 genotype-2b recombinant, arise from the genetic recombination of different HCV strains. These recombinants can exhibit unique properties and pose challenges for diagnosis and treatment .

Clinical Implications

The presence of recombinant HCV strains, including genotype-2b recombinants, has important clinical implications. These strains can affect the accuracy of genotyping methods, which are essential for determining the appropriate antiviral therapy . Additionally, recombinant strains may exhibit different responses to antiviral treatments, necessitating tailored therapeutic approaches .

Diagnostic and Therapeutic Challenges

Accurate genotyping of HCV is crucial for effective treatment. Traditional genotyping methods may struggle to identify recombinant strains, leading to potential misclassification and suboptimal treatment . Advanced techniques, such as sequencing of multiple genomic regions (e.g., core and NS5B), are employed to improve the accuracy of HCV genotyping and detect recombinant forms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.